The other clinicopathological parameters, including clinical stage, differentiation, tumor location, T/N classification, tumor volume, gross classification, vascular invasion, nerve invasion, and baseline parameters (sex and age), were not with correlation with the expression intensity of SCARA5 (Table 4). The gene discussed is SCARA5; the disease is neoplasm.